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Closure of the nasal cavities in the treatment of refractory
hereditary haemorrhagic telangiectasia
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Abstract
From a cohort of 35 patients with hereditary haemorrhagic telangiectasia (HHT), 12 patients have
undergone closure of the one or both nasal cavities during the last three years for refractory epistaxis. All
had failed other forms of treatment including hormone therapy, laser coagulation and septodermoplasty.
All patients were available for follow-up at six months or longer. In all patients where complete closure
was achieved (11 out of 12) bleeding ceased completely from the operated side.
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Introduction
The condition of hereditary haemorrhagic telangiec-
tasia (HHT) was first described in the 1860s by
Sutton (1864) and Babington (1865) although the
names of Osier, Rendu, and Weber (1901, 1896,
1907) are more commonly associated with the
condition. The hereditary nature of the vascular
defect responsible for the telangiectasia is auto-
somally dominant and non-sex linked.
The clinically established condition has been
recognised in all European races and can affect any
cutaneous or mucosal surface. Whilst the tongue,
skin and nail beds are generally 'protected', lesions
on the nasal mucosa, lips and gastrointestinal tracts
are particularly vulnerable to trauma. As a conse-
quence epistaxis is present in over 90 per cent of
afflicted individuals and serious nose bleeds occur by
the age of 30 in 80 per cent of patients (Harrison,
1956). Severe gastrointestinal bleeding and multiple
arterio-venous fistulae within the liver and lung can
also have serious clinical consequences but it is the
repeated nose bleeds which produce the most
physically and socially disabling problems for
patients.
A variety of treatment strategies have been
employed in addition to the usual first aid measures.
These include various forms of cautery and laser
coagulation, hormonal therapy with oestrogens and
progesterones, the use of antifribrinolytic agents
such as tranexamic acid and aminocaproic acid,
embolization and various forms of septodermo-
plasty. The clinical success in the short and long
term will vary from individual to individual and in
any group of patients one encounters those whose
nose bleeds continue to be an intractable and
debilitating problem. In these patients, airflow
alone provides sufficient trauma to produce bleeding
and an alternative therapeutic approach is to close
the nostril by a modification of Young's procedure.
Materials and method
From a cohort of 35 patients with HHT receiving
various forms of regular treatment, 12 individuals
have undergone a modified Young's procedure
designed to completely close the nasal cavity.
Closure was performed bilaterally in eight indivi-
duals on the first occasion but only on the worse side
in four, two of whom later requested closure of the
second side. There were six men and six women,
their ages ranging from 28 to 85 years (Table I).
Follow-up ranged from six months to 36 months,
mean 21 months. All patients had received previous
treatment with argon laser, hormones or septoder-
moplasty. All patients were suffering frequent severe
nose bleeds and were receiving regular iron supple-
ments and/or blood transfusions (10 out of 12).
Technique
When Taylor and Young described their proce-
dure in 1961, little detail was given on the precise
technique, other than to state that folds of skin were
raised inside the nostrils and sutured together. In the
authors' experience, the success of the procedure is
entirely dependent upon complete closure of the
nasal cavity. This is achieved by a circumferential
incision at the muco-cutaneous junction of the nasal
vestibule which is divided to form three anterior
flaps after infiltration with adrenalin 1:1000 under
general anaesthesia (Figure 1). These are then raised
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TABLE I
DETAILS OF PATIENTS UNDERGOING NASAL CLOSURE



































Cryotherapy, CO2 and argon laser, oral oestrogens,
septodermoplasty
Arterial ligation, radiotherapy, septodermoplasty, argon laser
Oral progesterone, septodermoplasty, argon laser
Argon laser
Oral progesterone, argon laser
Cryotherapy, KTP and argon laser, oral oestrogens
Aminocaproic acid, tranexamic acid, oral oestrogen and



















retrogradely towards the nasal aperture as atrau-
matically as possible. Great care should be taken to
avoid bleeding from the telangiectasia on the nasal
mucosa. The flaps must be sufficiently elevated to
allow a completely tension-free closure and may be
supported with gel foam soaked in adrenalin. This is
done with meticulously placed interrupted sutures of
4/0 catgut. A small amount of chloromycetin oint-
ment is applied to the area. Patients must be
instructed to avoid any trauma to the area in the
post-operative period. In exceptional cases where
advice is unlikely to be taken, a plaster of Paris cast
may be applied to the nose for seven to 10 days.
Results
In 11 of the 12 patients, complete closure of the
nasal cavity was achieved and this was associated
with complete cessation of bleeding. In the first
individual in whom the procedure was undertaken,
only two flaps were raised and a small dehiscence
occurred inferiorly through which some bleeding
continued. As a consequence the patient requested
that the nasal cavity be reopened. In those four
individuals where unilateral closure was performed
on their worse side, two subsequently requested
closure of the second side, again with complete
cessation of bleeding. Many patients are alarmed at
the prospect of complete nasal blockage but will
frequently agree to closure of the worst side. This is
FIG. 1
Schematic drawing of surgical technique showing: three flaps
before (right nostril) and after closure (left nostril).
only possible however in the absence of a septal
perforation which is sometimes present in patients
who have undergone previous bilateral septodermo-
plasty.
As a consequence of the modified Young's
procedure the need for regular blood transfusion
has disappeared and patients are now able to
undertake social activities hitherto impossible.
Discussion
HHT is a clinically and socially debilitating disease
in which epistaxis is one of the major symptoms. The
bleeding is sudden and often unpredictable, pre-
cipitated by minor actions such as drinking a cup of
tea or pulling a jumper over the head, which makes it
difficult to pursue a normal job and renders many
individuals house-bound creating an inevitable bur-
den on their family. Whilst many treatment strate-
gies are available none have proved entirely
successful for all individuals.
The underlying lesion comprises a large vascular
channel lined with a single layer of endothelial cells
of varying thickness on a continuous basement
membrane. Although smooth muscle cells are pre-
sent they do not form a complete perivascular layer
and no elastic tissue is present in relation to the
vascular spaces. This inherited defect involves not
only terminal but also large vessels as indicated by
the associated findings of arterio-venous fistulae
(Menefee et al., 1957; Jahnke, 1970). As a conse-
quence any trauma, however slight, may result in
bleeding which can be profuse in the absence of
normal vasoconstriction. Thus, normal first aid
measures such as packing the nose may actually
exacerbate the situation by creating further trauma
to the vessels. Septodermoplasty, described by
Saunders in 1960, aims to remove the mucosa from
those parts of the nose most affected by the
telangiectasia, i.e. the anterior part of the nasal
septum, nasal floor and as much of the lateral wall as
proves feasible. A split skin graft is generally used to
cover the denuded area though a variety of other
materials including amniotic membrane (Laurian et
al., 1979) and buccal mucosa have also been
suggested (Milton et al., 1993). Inevitably over a
period of time there is contraction of the graft and32 V. J. LUND, D. J. HOWARD
some revascularization, although this technique can
produce an amelioration of the symptoms for several
years (McCabe and Kelly, 1972; Harrison, 1982).
The use of systemic oestrogen was first proposed
by Koch et al. in 1952 and was popularized by
Harrison (1963, 1982). The resultant squamous
metaplasia from large doses of ethinyl oestradiol
significantly reduces the frequency and severity of
epistaxis but has inevitable side effects which most
male patients find unacceptable. In some male
subjects progesterone in doses of 20-30 mg a day
seems to offer some of the beneficial effects of
oestrogen but with diminished feminising side
effects, though some do describe the sensation of
bloating due to fluid retention and, occasionally,
quite severe pruritus (Richtsmeier et al., 1984).
Applications of caustic soda, submucosal injec-
tions of sclerosing fluids, local coagulation with
snake venom, and radiotherapy, have all been used
with little long-term benefit. However, more recently
precise coagulation with the argon, neodinium-YAG
and KTP laser can offer reasonable palliation for
mild to moderately affected patients (Shapsay and
Oliver, 1984; Ilium and Bjerring, 1988; Siegel et al.,
1991).
It is clear, therefore, that a cohort of patients exists
whose epistaxes have proved refractory to many
forms of treatment and who represent a significant
management problem. In 1961 Taylor and Young
described closure of the nostril in the treatment of
atrophic rhinitis in a review of 10 patients (five
children and five adults). In 1967, Young described
his patients' reaction to the procedure as mixed but
felt that the disadvantages were outweighed by the
advantages in controlling the condition. Most
patients described dryness due to mouth breathing
and five individuals subsequently underwent tonsil-
lectomy. No adverse effect was reported on the
dentition. In five cases the nostrils were reopened,
though the problems of vestibular stenosis are
mentioned only in passing. In 1991, Brooker and
Cinnamond described two cases of epistaxis due to
self-inflicted trauma, in one case of which closure of
the nostril was performed. In 1993, Gluckman and
Portugal presented three cases to the American
Triologic Society in whom a modified Young's
procedure had been used in the treatment of
hereditary haemorrhagic telangiectasia. A more
complex technique than that implied by Young was
employed, involving the raising of circumferential
skin and mucosal flaps via an alarotomy-releasing
incision. These individuals had failed other treat-
ment options including neodymium-YAG laser,
oestrogen therapy and septodermoplasty and were
available for five, seven and eight year follow-up.
These cases were published in 1994 coincident with
two cases reported by Hosni and Innes.
Most patients are less than enthusiastic at the
prospect of complete nasal obstruction fearing
problems with respiration, particularly at night and
the consequences of a nose bleed after nasal closure.
As bleeding is extremely unlikely after the operation
and as the adult human is only a facultative nasal
breather, they can be reassured on both scores.
However, unilateral closure of the worse side may be
one way of allaying their concerns with a view to
closure of the second side at a later date. This can
only be done in the absence of a septal perforation.
It has been our experience that only complete
cessation of airflow is effective in preventing
epistaxis. In all 11 cases where total closure has
been achieved, bleeding has completely ceased. This
was also the experience of Gluckman and Portugal
(1994) but it was not the case in two individuals
reported by Hosni and Innes (1994). Re-opening of
the nose would almost certainly be associated with
clinical relapse so patients should regard closure as
permanent. Notwithstanding this, the benefits of cure
are regarded by the patients (and their families) as
significantly outweighing the disadvantages.
Conclusion
In the management of HHT, a range of treatment
options are available and must be selected on an
individual basis. However, in those suffering from
severe refractory epistaxis, the most effective results
are achieved by permanently preventing air flow
through the nasal cavity by a modified Young's
procedure. This inevitably produces complete nasal
obstruction but is an acceptable price for such a
successful clinical outcome. The effectiveness of this
relatively simple technique is enormously gratifying
for both the patients and the surgeon and the
excellent long-term results offer a much needed
addition to our therapeutic options in this difficult
and debilitating condition.
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